Makary’s Reorganization Decision A Turning Point For US FDA?

 
• By Michael McCaughan
  
Without a major reorganization to worry about, FDA staff may be able to adjust to the new normal. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Agency Leadership